• Tue news: Novo looks to speed up India Wegovy launch. 4 revelations from MN’s 340B transparency report. 4 oral GLP-1R’s in dev. Roche autoimmune partnership. Gilead-Tubulis alliance. See more on our front page

pharmaceutical company

  1. Eagle Pharmaceuticals

    Tell me about Eagle. The CEO resigned last year, the CFO this year. What is going on there? Is it normal?
  2. INFINITY & MEI PHARMA MERGER

    was wondering if anyone works for either company or have any details on this merger that was announced ?? what can I expect market wise?
  3. Abbvie Stop Wasting Candidates Time

    Abbvie we know you have to post new job listing for 5 days. You pull post because you filled with internal after people applied. Even worse is your recruiters line up 1-2 sacrificial external candidates who don’t have a chance in hell but you put them through several rounds knowing current...
  4. prescription data & kickbacks at Insys

    I'm a writer working on a story for publication re: the impact of IQVIA (and similar) data on healthcare. Did INSYS use prescription data to allocate kickbacks based on prescription volume of certain docs? You can reach me at: medwriter963@gmail.com. Thank you.
  5. PDRP violations

    I am a medical writer looking for someone willing to go on the record regarding violations of PDRP (physician data restriction program) by drug manufacturers. That is, I'm interested knowing about prescription info of PDRP doctors being made available to drug reps. I look forward to hearing...
  6. Pharma Dirt?

    I'm conducting a Big Pharma research project, I have some basic evidence, but does anyone have anything to any use? Anything they want to dish?
  7. Modern Pharma Companies' Challenges Are No Different to Any Other Start-Up

    What do startups and modern pharma companies have in common? There are two factors mentioned in article Embracing the Start-up Mindset in Pharma : the increasing trend [...] to pay a value-based price for value actually delivered and not just for the physical product itself the increasing...
  8. Arrowhead Pharma doesn't report Q4 financials in press release

    Arrowhead Pharmaceuticals reports a loss of $0.12 per share in Q4 2018. Arrowhead doesn't report Q4 numbers in the quarterly press release. They only report Q4 numbers in the SEC filing.
  9. Merck joins pharma giants in lowering drug prices

    The latest pharma giant to bow to Trump’s pressure on drug price is Merck (MRK). The company announced on Thursday that it would lower price on at least six of its drug in the US by 10% or more. https://news.alphastreet.com/merck-joins-pharma-giants-in-lowering-drug-prices/
  10. Pfizer this year: Headwinds and tailwinds

    Pfizer (PFE) is an interesting stock to follow. Apart from being a great dividend stock, the company also boasts of a diversified portfolio, strong free cash flow, and consistency in beating earnings expectations. Let’s quickly take a look at the pros and cons...
  11. With Rite Aid stores under its wings, Walgreens prepares to take down rivals

    Upping its ante against its rivals in the medical and pharma sector, Walgreens has finally completed its acquisition of Rite Aid’s stores for $4.4billion. The deal brings 1,932 Rite Aid stores as well as three distribution centers under the umbrella of Walgreens. Though Walgreens initially...
  12. Is Johnson & Johnson a ‘sell’ in 2018?

    Johnson & Johnson may not be having a great 2018 so far with the stock ticking down about 8% since the year started. But is it time to get rid of the world’s largest pharma company’s shares? Let’s see.
  13. Albertsons to merge with Rite Aid

    Privately-held Albertsons Companies is planning to buy the portion of Rite Aid that is not being sold to Walgreens Boots Alliance. The combined value of Albertsons and Rite Aid, including debt, is around $24 billion. The proposed cash-and-stock deal will give Albertsons shareholders ownership...
  14. Columbia University Student Requesting Assistance with Clinical Trials Matching Survey

    Hello, my colleagues and I at Columbia University are collecting data on cancer clinical trials to better understand the needs of the healthcare community. Please respond to the below questions and thank you in advance for taking the time to complete this questionnaire...